報價延遲最少15分鐘:2025/11/07 13:27 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
40.2728 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.53/0.65
|
|
企業價值
9.46B
|
| 資產負債 |
|
每股賬面淨值
2.55
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
1.48B
|
|
每股收益
3.48
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/11/07 13:27 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers. |
